Arcus Biosciences (NYSE: [[ticker:RCUS]]) has appointed Eric Hoefer to serve as chief commercial officer. Hoefer most recently worked at AstraZeneca (NYSE: [[ticker:AZN]]), where he led immune-oncology global marketing. His experience also includes posts at Roche and Genentech. Hayward, CA-based Arcus raised $120 million in an IPO last year to fund clinical development of its experimental cancer immunotherapies.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
